Attorneys: PDMA isn't broken, don't change it

Share this article:

Two Hyman, Phelps & McNamara attorneys have told the US Sentencing Commission that the guideline for misdemeanor offenses under the Prescription Drug Marketing Act isn't broken and shouldn't be changed. The FDA asked the commission to consider changing the guideline because its maximum prison term isn't enough.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.